Astsaturov, I. Et Al. 2003. Amplification of virus-induced antimelanoma T-cell reactivity by high-dose interferon-alpha 2b: Implications for cancer vaccines. CLINICAL CANCER RESEARCH , vol.9, no.12 , 4347-4355.

Astsaturov, I., Petrella, T., Bagriacik, E. Ü., de Benedette, M., Uger, R., Lumber, G., ... Berinstein, N.(2003). Amplification of virus-induced antimelanoma T-cell reactivity by high-dose interferon-alpha 2b: Implications for cancer vaccines. CLINICAL CANCER RESEARCH , vol.9, no.12, 4347-4355.

Astsaturov, I Et Al. "Amplification of virus-induced antimelanoma T-cell reactivity by high-dose interferon-alpha 2b: Implications for cancer vaccines," CLINICAL CANCER RESEARCH , vol.9, no.12, 4347-4355, 2003

Astsaturov, I Et Al. "Amplification of virus-induced antimelanoma T-cell reactivity by high-dose interferon-alpha 2b: Implications for cancer vaccines." CLINICAL CANCER RESEARCH , vol.9, no.12, pp.4347-4355, 2003

Astsaturov, I. Et Al. (2003) . "Amplification of virus-induced antimelanoma T-cell reactivity by high-dose interferon-alpha 2b: Implications for cancer vaccines." CLINICAL CANCER RESEARCH , vol.9, no.12, pp.4347-4355.

@article{article, author={I Astsaturov Et Al. }, title={Amplification of virus-induced antimelanoma T-cell reactivity by high-dose interferon-alpha 2b: Implications for cancer vaccines}, journal={CLINICAL CANCER RESEARCH}, year=2003, pages={4347-4355} }